Access Biotechnology is in line for an exit after the neuronal excitability disorder drug developer filed to float on the Nasdaq Global Market.

The fashion rental service has confidentially filed to go public having already raised some $337m from investors including Advance Publications and American Express.

The CSAA-backed digital home insurance provider is joining forces with a special purpose acquisition company at a valuation just over $1bn.

Harvard spinout TScan Therapeutics has successfully listed on the Nasdaq Global Market.

Paccar, Uber and Volvo Group are taking part in a $1bn PIPE supporting the autonomous driving technology developer’s reverse merger with Reinvent Technology Partners.

The Salesforce-backed banking software producer floated at the top of its range and saw its shares rise on their first day of trading.

The Alphabet, Astellas, Novartis and WuXi AppTec-backed cancer therapy developer priced its shares at the foot of their range in an upsized offering.

The corporate-backed mobile payments app’s parent company, One97 Communications, has filed to float in an offering set to include $1.1bn of existing share sales.

Pharmaron, Celgene, Amgen and Merck & Co-backed Imago BioSciences floated in an IPO today, alongside a private placement transaction featuring Pfizer.

The IGBMC spinout was set up by Satt Conectus and is now seeking a listing in the US with a price range of $15 to $17.